van den Dries, C. J., Pajouheshnia, R. ., van den Ham, H. A., Souverein, P. ., Moons, K. G. M., Hoes, A. W., … van Doorn, S. . (2022). Safety of off-label dose reduction of non-vitamin K antagonist oral anticoagulants in patients with atrial fibrillation. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.15534
H. van den Ham
First name
H.
Middle name
A.
Last name
van den Ham
van den Ham, H. A., Klungel, O. H., Leufkens, H. G., & van Staa, T. P. (2013). The patterns of anticoagulation control and the risk of stroke, bleeding and mortality in patients with non-valvular atrial fibrillation. J Thromb Haemost. http://doi.org/10.1111/jth.12041
van den Ham, H. A., Klungel, O. H., Singer, D. E., Leufkens, H. G., & van Staa, T. P. (2015). Comparative Performance of ATRIA, CHADS2, and CHA2DS2-VASc Risk Scores Predicting Stroke in Patients With Atrial Fibrillation: Results From a National Primary Care Database. J Am Coll Cardiol. http://doi.org/10.1016/j.jacc.2015.08.033
Gieling, E. M., van den Ham, H. A., van Onzenoort, H. ., Bos, J. ., Kramers, C. ., de Boer, A. ., … Burden, A. M. (2017). Risk of major bleeding and stroke associated with the use of vitamin K antagonists, nonvitamin K antagonist oral anticoagulants and aspirin in patients with atrial fibrillation: a cohort study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.13265
Zhang, Y. ., Souverein, P. C., Gardarsdottir, H. ., van den Ham, H. A., van der Zee, A. H. M.-., & de Boer, A. . (2020). Risk of major bleeding among users of direct oral anticoagulants combined with interacting drugs: A population-based nested case-control study. Br J Clin Pharmacol. http://doi.org/10.1111/bcp.14227
van den Dries, C. J., van Doorn, S. ., Souverein, P. ., Pajouheshnia, R. ., Moons, K. G. M., Hoes, A. W., … van den Ham, H. A. (2020). The Number of Concomitant Drugs and the Safety of Direct Oral Anticoagulants in Routine Care Patients with Atrial Fibrillation. TH Open. http://doi.org/10.1055/s-0040-1721499
Gulluoglu, R. ., Souverein, P. C., van den Ham, H. A., de Boer, A. ., & Komen, J. . (2020). Comparative effectiveness and safety of direct oral anticoagulants versus warfarin in UK patients with atrial fibrillation and type 2 diabetes: A retrospective cohort study. Pharmacoepidemiol Drug Saf. http://doi.org/10.1002/pds.5181